MarkAllenStacyMD

PubMed

• 4201 citations
  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
  Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn
  Movement Disorders. 2008-11-15
• 45 citations
  Clinical features of patients with blepharospasm: a report of 240 patients
  Elizabeth Peckham, Grisel Lopez, Ejaz A. Shamim, S. Pirio Richardson, S. Sanku
  European Journal of Neurology. 2011-03-01
• 222 citations
  Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease
  Erika Driver-Dunckley, J. Samanta, Mark Stacy
  Neurology. 2003-08-12

Journal Articles

• Rapid-onset Dystonia-parkinsonims Associated with the 1758s Mutation of the ATP1A3 Gene: A Neuropathologic and Neuroanatomical Study of Four Siblings  
  Oblak AL, Hagen MC, Sweadner KJ, Haq I, Whitlow CT, Maldjian JA, Epperson F, Cook JF, Stacy M, Murrell JR, Ozelius LJ, Brashear A, Ghetti B, Acta Neuropathol, 7/1/2014
• Cognitive Impairment in Rapid-onset Dystonia-parkinsonism  
  Cook JF, Hill DF, Snively BM, Boggs N, Suerken CK, Haq I, Stacy M, McCall WV, Ozelius LJ, Sweadner KJ, Brashear A, Mov Disord, 1/16/2014
• A New Approach to Disease-modifying Drug Trials in Parkinson's Disease  
  Barker RA, Stacy M, Brundin P, J Clin Invest, 5/20/2013
• AAV2-neurtutin (CERE-120) for Parkinson's Disease  
  Hickey P, Stacy M, Expert Opin Biol Ther, 1/1/2013
• Which Dyskinesia Scale Best Detects Treatment Response? A Double-blind Placebo Controlled Trial Using Multiple Dyskinesia Measures  
  Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy M, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S, Mov Disord, 1/1/2013
• Safety/Feasibility of Targeting the Substantia Nigra with AAV2-Neurturin in Parkinson's Disease  
  Bartus RT, Baumann TL, Siffert J, Herzog CD, Alterman R, Boulis N, Turner D, Stacy M, Lang AE, Lozano AM, Olanow CW, Neurology, 1/1/2013
• Extended-release Carbidopa-levodopa (IPX066) Compared with Immediate-release Carbidopa-levodopa in Patients with Parkinson's Disease and Motor Fluctuations: A Phase 3 ...  
  Hauser RA, Hsu A, Kell S, Espay AJ, Sethi K, Stacy M, Ondo W, O'Connell M, Gupta S; IPX066 ADVANCE-PD investigators, Lancet Neurol, 1/1/2013
• AFQ056 in Parkinson Patients with L-dopa-induced Dyskinesia: 13-week Randomized, Controlled, Dose-finding Study  
  Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C, Mov Disord, 1/1/2013
• ATP1A3 Mutations in Infants: A New Rapid-onset Dystonia-Parkinsonism Phenotype Characterized by Motor Delay and Ataxia  
  Brashear A, Mink JW, Hill DF, Boggs N, McCall WV, Stacy M, Snively B, Light LS, Sweadner KJ, Ozelius LJ, Morrison L, Dev Med Child Neurol, 11/1/2012
• Cognitive Impairment in Rapid-Onset Dystonia Parkinsonism  
  Brashear A, Cook JF, Hill DF, Amponsah A, Snively B, Boggs N, Suerken CK, Haq I, Stacy M, Ozelius L, Sweadner KJ, McCall WV, Mov Disord Neurology, 9/1/2012
• Istradefylline for Parkinson's Disease Patients Experiencing Motor Fluctuations: Results of the KW-6002-US-018 Study  
  Pourcher E, Fernandez HH, Stacy M, Mori A, Ballerini R, Chaikin P, Parkinsonism Relat Disord, 1/1/2012
• Psychiatric Disorders in Rapid-Onset Dystonia Parkinsonism  
  Brashear A, Cook JF, Hill DF, Amponsah A, Snively B, Light L, Boggs N, Suerken CK, Stacy M, Ozelius L, Sweadner KJ, McCall WV, Neurology, 1/1/2012
• New Triggers and Non-motor Findings in a Family with Rapid-onset Dystonia-parkinsonism  
  Barbano RL, Hill DF, Snively BM, Light LS, Boggs N, McCall WV, Stacy M, Ozelius L, Sweadner KJ, Brashear A, Parkinsonism Relat Disord, 1/1/2012
• Istradefylline for the Treatment of Parkinson's Disease  
  Park A, Stacy M, Expert Opin Pharmacother, 1/1/2012
• The Economic and Quality of Life Burden Associated with Parkinson's Disease: A Focus on Symptoms  
  Boland D, Stacy M, Amer J Managed Care, 1/1/2012
• Patient Perspectives on Parkinson's Disease Therapy in Japan and the United States: Results of Two Patient Surveys  
  Hattori N, Fujimoto K, Kondo T, Murata M, Stacy M, Patient Relat Outcome Meas, 1/1/2012
• Research Management Team (RMT): A Model for Research Support Services at Duke University  
  Snyder DC, Epps S, Beresford HF, Ennis C, Levens JS, Woody SK, Tcheng JE, Stacy M, Nahm M, Clinical and Translational Science, 1/1/2012
• Meta-analysis of Parkinson's Disease: Identification of a Novel Locus, RIT2  
  PD GWAS Consortium, Ann Neurol, 1/1/2012
• Design Innovations and Baseline Findings in a Long-term Parkinson's Trial: The National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson'...  
  Elm JJ; NINDS NET-PD Investigators, Mov Disord, 1/1/2012
• Efficacy, Tolerability, and Immunogenicity of Onabotulinumtoxina in a Randomized, Double-blind, Placebo-controlled Trial for Cervical Dystonia  
  Charles D, Brashear A, Hauser RA, Li HI, Boo LM, Brin MF; CD 140 Study Group, Clin Neuropharmacol, 1/1/2012
• Wearing-off Scales in Parkinson's Disease: Critique and Recommendations  
  Antonini A, Martinez-Martin P, Chaudhuri RK, Merello M, Hauser R, Katzenschlager R, Odin P, Stacy M, Stocchi F, Poewe W, Rascol O, Sampaio C, Schrag A, Stebbins GT, Go..., Mov Disord, 10/1/2011
• Clinical Features of Patients with Blepharospasm: A Report of 240 Patients  
  Peckham EL, Lopez G, Shamim EA, Richardson SP, Sanku S, Malkani R, Stacy M, Mahant P, Crawley A, Singleton A, Hallett M, Eur J Neurol, 3/1/2011
• Available and Emerging Treatments for Parkinson's Disease: A Review  
  Hickey P, Stacy M, Drug Des Devel Ther, 1/1/2011
• Impulse Control Disorders in Parkinson Disease: A Multicenter Case--control Study  
  Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M, Ann Neurol, 1/1/2011
• Nonmotor Symptoms in Parkinson's Disease  
  Stacy M, Int J Neurosci, 1/1/2011
• Join now to see all

Books/Book Chapters

• Handbook of Dystonia 
  Stacy MEditors: Stacy M.Informa, PhiladelphiaEdition 2nd,2012
• Psychiatry of Parkinson's Disease 
  Chapter: Psychosis and Parkinson's Disease 
  Page 53 - 60Jakel RJ, Stacy MEditors: Ebmeier KP, O'Brien J, Taylor J- P.Karger, Basel2012
• Uncommon Causes of Movement Disorders 
  Chapter: Unusual Causes of Tremor 
  Johnson J, Stacy MEditors: BMJ Point of Care.Cambridge University Press2011
• BMJ Point of Care 
  Chapter: Acquired Torticollis 
  Sommer D, Stacy M2010
• The Non-Motor and Non-Dopaminergic Features of Parkinson's Disease 
  Chapter: Overview of Medical Treatment of Non-motor Features in Parkinson's Disease 
  Stacy M, Jankovic JEditors: Olanow CW, Stocchi F, Lang AE.Blackwell Publishing, New York2010
• Faculty of 1000 
  Chapter: A Controlled Trial of Antidepressants in Patients with Parkinson Disease and Depression 
  Stacy M2009
• Movement Disorders 
  Chapter: Progressive Supranuclear Palsy 
  Samanta JES, Stacy MEditors: Truong D.Cambridge University Press2009
• Movement Disorders 
  Chapter: Tic Disorders 
  Suski V, Stacy MEditors: Truong D.Cambridge University Press2009
• Faculty of 1000 
  Chapter: Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease 
  Stacy M2008
• Movement Disorders: 100 Instructive Cases 
  Chapter: Hemiballismus 
  Beuchler R, Stacy MEditors: Reich S.Informa, Philadelphia2008
• Annual Review of Neurology 
  Chapter: Parkinson's Disease and Movement Disorders 
  Stacy MEditors: Hallet M.Oxford Press2008
• Faculty of 1000 
  Chapter: Imaging Amyloid Deposition in Lewy Body Diseases 
  Stacy M2008
• Neurobase 
  Chapter: Post-traumatic Movement Disorders 
  Sathornsumetee S, Stacy M2008
• Faculty of 1000 
  Chapter: Pathologic Findings in Prospectively Ascertained Essential Tremor Subjects 
  Stacy M2008
• Faculty of 1000 
  Chapter: Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism 
  Stacy M2008
• Faculty of 1000 
  Chapter: Impulse Control Disorders 
  Stacy M2008
• Neurobase 
  Chapter: Catatonia 
  Stacy M2008
• Handbook of Dystonia 
  Chapter: Clinical Use of the Botulinum Toxins 
  Page 357 - 369Stacy MEditors: Stacy M.Taylor & Francis, Philadelphia2007
• Parkinson's Disease: Diagnosis and Clinical Management 
  Chapter: Adenosine A2A Receptor Antagonists in the Treatment of Parkinson's Disease 
  Menon RN, Stacy MEditors: Factor SA and Weiner WJ.Butterworth2007
• Parkinson's Disease: Questions and Answers 
  Chapter: Case Studies in Parkinson's Disease 
  Page 197 - 212Stacy MEditors: Hauser R.2007
• Neurobase 
  Chapter: Amebic Meningoencephalitis 
  Sathornsumetee S, Stacy M, Roos RP2007
• Handbook of Dystonia 
  Stacy MEditors: Stacy M.Taylor & Francis, Philadelphia2006
• Neurobase 
  Chapter: Limb Dystonia 
  Stacy M, Tsui J2006
• Seminars in Neurology 
  Chapter: Generalized Dystonia and Limb Dystonia 
  Page 23 - 30Stacy MEditors: Jankovic J.Demos Medical Publishing, New York2005
• Rating Scales for Dystonia: Assessment of Reliability of 3 Scales 
  Chapter: Dystonia 4 
  Page 329 - 336The Dystonia Study GroupRaven Press2005
• Join now to see all

Abstracts/Posters

• Safety and Feasibility of Intranigral and Intraputaminal CERE-120 (AAV2-neurturin) Administration in Parkinson's Disease
  Siffert J, Stacy M, Turner D, Tagliati M, Alterman R, Factor S, Boulis N, Olanow CW, Lang AE, Lozano A, Bartus RT, Movement Disorders Society, Dublin, 1/1/2012
• A 13-week, Double-blind, Placebo-controlled Study of AFQ056, a Metabotropic Glutamate Receptor 5 Antagonist in Parkinson's Disease Patients with Moderate-to-severe L-d...
  Stocchi F, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Rascol O, Stacy M, Tolosa E, Trenkwalder C, Gao H, Nagel J, Gomez-Mancilla B, Merschhemke M, Tekin S, Abi-..., Movement Disorders Society, Buenos Aires, 1/1/2011
• Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE): Interim Results of Physician- and Patient-Reported Outcomes
  Jankovic J, Stacy M, Charles D, Adler C, Brin M, Papapetropoulos S, and the CD PROBE Study Group, International Dystonia Symposium, 1/1/2011
• CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX(R) Efficacy) - A Multicenter, Observational Study of Repeated Botulinum Toxin Type-A Injections i...
  Jankovic J, Charles D, Comella CL, Stacy M, Adler CH, Misell LM, Kurth M, Manasee V Shah BMV, Brin MK, Boo LM, American Academy of Neurology, Toronto, 1/1/2010
• CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX(R) Efficacy) - A Multicenter, Observational Study of OnabotulinumtoxinA Injections in Cervical Dy...
  Charles D, Adler CH, Comella CL, Jankovic J, Stacy M, Kurth M, Brin MK, Boo LM, American Association of Physical Medicine and Rehabilitation, Seattle, 1/1/2010
• Compliance and Persistence to Single-tablet Levodopa/carbidopa/entacapone Compound versus Levodopa/carbidopa in Idiopathic Parkinson's Disease
  Stacy M, Laliberte F, Kulkarni AS, Somogyi M, Vekeman F, Duh M-S, Lefebvre P, American College of Clinical Pharmacy, Austin, TX, 1/1/2010
• Impact of Levodopa/carbidopa/entacapone Compound versus Levodopa/carbidopa on Hospitalization Rates in Patients with Idiopathic Parkinson's Disease
  Stacy M, Laliberte F, Kulkarni AS, Somogyi M, Vekeman F, Duh M-S, Lefebvre P, American College of Clinical Pharmacy, Austin, TX, 1/1/2010
• Study Design of MOTION: A 24-week, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Safinamide in Early Parkinson's Disease
  Barone P, Fernandez H, Ferreira JJ, Müller T, Saint-Hilaire M, Stacy M, Tolosa E, von Raison F, Kenney C, Musch B, European Federation of Neurological Societies, Geneva, 1/1/2010
• Patient Perspectives towards Levodopa Therapy in Japan and the United States - Results of Two Patient Surveys
  Hattori N, Fujimoto K, Kondo T, Murata M, Stacy M, World Parkinson Congress, Glasgow, 1/1/2010
• Factors Associated with Impulse Control Disorders in Parkinson's Disease: A Case Control Study of 584 Subjects
  Voon V, Koester J, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M, American Academy of Neurology, Seattle, 1/1/2009
• A Randomized, Double-Blind Evaluation of Levodopa/Carbidopa/Entacapone Versus Immediate-Release Levodopa/Carbidopa in Patients With Parkinson's Disease Exhibiting Non­...
  Stacy M, McCague K, Weidenman M, Campbell A, Somogyi M, American Academy of Neurology, Seattle, 1/1/2009
• Multicenter, Randomized, Double-Blind, Sham Surgery-Controlled Study of Intraputaminal AAV2-Neurturin (CERE-120) for Advanced Parkinson´s Disease
  Marks WJ, Bartus RT, Siffert J, Starr PA, Ostrem J, Larson PL, Stacy M, et al., World Federation of Neurolgy, 1/1/2009
• Dopaminergic Therapy and Impulse Control Disorders in Parkinson's Disease: A Cross-Sectional Study of Over 3,000 Patients
  Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy MA, Whetteckey J, MD, Wunderlich GR, Lang, AE for the DOMINION Study Group, 11th International Congress of Parkinson's Disease and Movement Disorders, Chicago, 1/1/2008
• The Essential Tremor Rating Assessment Scale (TETRAS)
  Elble R for the Tremor Research Group (TRG), 11th International Congress of Parkinson's Disease and Movement Disorders, Chicago, 1/1/2008
• Is There a Role of Somatization in the Manifestation of Non-motor Symptoms of Parkinson's Disease?
  Murck H, Stacy M, Koumaris B, Meng S, Kroenke K, Annual Meeting of the American Psychiatric Association, San Diego, 5/19/2007
• Impulse Control Disorders Arising in Three Patients Treated with Rotigotine
  Wingo TS, Evatt M, Scott B, Freeman A, Stacy M, Impulse Control Disorders in Parkinson's Disease, Toronto, 1/1/2007
• Improved Compliance with Levodopa/carbidopa/entacapone (Stalevo(R)) Or Levodopa/carbidopa and Entacapone as Separate Tablets Reduces Medical Care Utilization and Costs...
  Delea T, Thomas S, Hagiwara M, Stacy M, World Federation of Neurology, 1/1/2007
• Depression in a Cohort of 1335 Individuals with Familial Parkinson Disease
  Parkinson Study Group - PROGENI Investigators, Neurology, 1/1/2007
• Identifying Predictors of Somnolence and Edema in Patients with Early Parkinson's Disease Treated with Pramipexole: A Secondary Analysis of the CALM-PD Study
  Biglan KM, Brocht A, McDermott M, Kieburtz K, Parkinson Study Group CALM-PD Investigators, Mov Disord, 1/1/2007
• Identifying Predictors of Response to Pramipexole Treatment in Early Parkinson's Disease: A Secondary Analysis of the CALM-PD Study
  Biglan KM, Brocht A, McDermott M, Kieburtz K, Parkinson Study Group CALM-PD Investigators, Mov Disord, 1/1/2007
• Mutations in LRRK2 other than G2019S Are Rare in Familial Parkinson Disease
  Parkinson Study Group-PROGENI Investigators, The American Society of Human Genetics, New Orleans, LA, 10/9/2006
• R1514Q Substitution in LRRK2 Is Not a Pathogenic Parkinson Disease (PD) Mutation
  The Parkinson Study Group-PROGENI Investigators, The American Society of Human Genetics, New Orleans, LA, 10/9/2006
• Ropinirole 24-hour Prolonged Release Reduces 'off' Time and Improves Depression When Used as Adjunctive Therapy in Patients with Parkinson's Disease Not Optimally Cont...
  RL Hauser, N Stover, BL Hersh, 20th Annual Symposisa on Etiology, Pathogenesis and Treatment of Parkinson's Disease and Other Movement Disorders, Chicago, IL, 10/8/2006
• Apomorphine as a Diagnostic Tool for Parkinson's Disease
  Koller WJ, Stacy M, World Parkinson Congress, 2/22/2006
• Implications of Motor Fluctuations in Parkinson's Patients on Chronic Therapy (IMPACT): Comparison of Patient- and Physician-Reported Data
  Stacy M, Spears JB, Van Lunen BE, World Parkinson Congress, 1/1/2006
• Join now to see all

Lectures

• Treatment of the Advancing Parkinson's Disease Patient 
  New Orleans, LA - 1/1/1996
• Medications Used in Parkinson's Disease 
  1/1/1995
• Recognition and Treatment of Parkinson's Disease and Other Tremor Disorders 
  Boston, MA - 1/1/1994
• Treatment of Severe Motor Fluctuations in Parkinson's Disease 
  San Diego, CA - 1/1/1992
• Join now to see all

Other

• DaTSCAN Imaging in Parkinsonian Syndromes and Tremor Disorders 
  
  1/1/2011
• Impulse Control Disorders in Parkinson's Disease 
  CNN
  1/1/2008
• Wearing off Symptoms in Parkinson's Disease 
  
  1/1/2007
• Management of Wearing off in Parkinson's Disease; A Panel Discussion 
  
  1/1/2005
• Controversies In the Management of Parkinson's Disease 
  
  1/1/2005
• Treatment Strategies in Parkinson's Disease 
  
  1/1/2004
• Insights into the Treatment of Parkinson's Disease 
  
  1/1/2004
• Treatment of Parkinson's Disease 
  
  1/1/2003
• The Man with a Shaking Hand 
  York D, Stacy M, University of Missouri Problem Based Learning Curriculum
  1/1/1994
• DuPont Pharma, Insights into the Treatment of Parkinson's Disease 
  
  1/1/1993
• Children's Miracle Network Telethon, Tourette Syndrome 
  
  1/1/1993
• DuPont Pharma, Treatment Strategies in Parkinson's Disease 
  
  1/1/1992
• Join now to see all